Biomedicine

腺病毒载体新冠疫苗

Adenoviral Vector COVID-19 Vaccine

A vaccine platform utilizing a replication-deficient adenovirus to deliver the SARS-CoV-2 spike protein gene into host cells to elicit an immune response / 一种利用复制缺陷型腺病毒将SARS-CoV-2刺突蛋白基因递送至宿主细胞以引发免疫反应的疫苗平台

Knowledge type: 实际应用
First proposed or discovered
Proposer: Turkey Farm member
Creator: 农场主
Last updated: 2026-11-14 16:06:45

Sub-knowledge points

Replication-deficient adenoviral vectorSpike protein expressionCellular and humoral immune response

Higher-order knowledge points

mRNA VaccinesLive-attenuated Vaccines

Main parameters and performance indicators

Vector: Adenovirus (serotype 5 or 26)Antigen: SARS-CoV-2 Spike (S) proteinDelivery Mechanism: Gene transfer via viral vector

Open problems

Rare risk of thrombosis with thrombocytopenia syndrome (TTS)Potential for vector immunity reducing efficacy upon booster doses

Related literature

ranked by community stars

No Additional Cancer Risk Associated With Adenoviral Vector COVID-19 Vaccine Relative to mRNA Vaccines: A Nationwide Matched Cohort StudyOpen source

腺病毒载体新冠疫苗

Sub-knowledge points

Higher-order knowledge points

Main parameters and performance indicators

Open problems

Related products and links